ImmunityBio Inc. Stock
Price
Target price
€4.76
€4.76
6.890%
0.31
6.890%
€10.00
25.04.24 / Tradegate
WKN: A2QQ2E / Name: ImmunityBio / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
ImmunityBio Inc. Stock
A very strong showing by ImmunityBio Inc. today, with an increase of €0.31 (6.890%) compared to yesterday's price.
Our community is currently high on ImmunityBio Inc. with 3 Buy predictions and 0 Sell predictions.
Based on the current price of 4.76 € the target price of 10 € shows a potential of 110.13% for ImmunityBio Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for ImmunityBio Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of ImmunityBio Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ImmunityBio Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ImmunityBio Inc. | 6.890% | -8.629% | -20.354% | 102.703% | -4.661% | -70.960% | - |
| Ardelyx Inc. | -2.390% | -2.116% | -15.296% | 40.514% | 4.048% | -12.204% | - |
| Salarius Pharmaceuticals Inc. | -3.170% | 2.315% | -15.000% | -67.971% | -20.360% | -98.187% | -99.994% |
| Brainstorm Cell | 1.170% | -1.874% | -1.485% | -81.975% | 114.440% | -80.717% | - |
Comments
News
5 Stocks with Unusually Large Short Interest
With the broader market reaching new all-time highs, primarily driven by the tech sector and specifically semiconductor stocks fueled by the hype surrounding AI, the spotlight is once again
